Last Updated: November 9, 2026

Litigation Details for EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc. (Fed. Cir. 2015)

« Back to Dashboard


Small Molecule Drugs cited in EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc.
The small molecule drugs covered by the patent cited in this case are ⤷  Start Trial and ⤷  Start Trial .

Litigation summary and analysis for: EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc. (Fed. Cir. 2015)

Last updated: September 30, 2026

EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc. ended with the Federal Circuit affirming invalidity under 35 U.S.C. § 101. The court held that U.S. Patent No. 8,644,038 claimed the abstract idea of communicating with and controlling remote devices through a network using conventional technology. The decision limited the patent’s ability to support infringement claims against smart-meter and machine-to-machine communications companies.

EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc. Patent Litigation Summary

What was the EON Corp. v. Silver Spring Networks case about?

EON alleged that Silver Spring Networks infringed U.S. Patent No. 8,644,038, titled “Networked System for Monitoring and Controlling Remote Devices.” The patent concerned systems for communicating with multiple remote devices through a network and monitoring or controlling those devices.

The Federal Circuit affirmed the district court’s judgment that the asserted claims were invalid under Section 101 because they were directed to an abstract idea and lacked an inventive concept.

Item Details
Case EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc.
Federal Circuit docket No. 15-1237
Decision 815 F.3d 1314
Decision date March 23, 2016
Court U.S. Court of Appeals for the Federal Circuit
Patent U.S. Patent No. 8,644,038
Technology Networked monitoring and control of remote devices
Key issue Patent eligibility under 35 U.S.C. § 101
Result Affirmed invalidity of the asserted claims
Principal defendants identified in caption Silver Spring Networks, Inc.

The opinion applied the two-step framework from Alice Corp. v. CLS Bank International and Mayo Collaborative Services v. Prometheus Laboratories, Inc. (Alice, 2014; Mayo, 2012).

What patents protected EON’s remote-device communications technology?

The principal patent was U.S. Patent No. 8,644,038. The patent described a networked system with remote units, a communications network, and a control station or server capable of communicating with and controlling the remote units.

The patent’s commercial relevance was linked to technologies used in utility metering, distributed sensors, remote monitoring, and machine-to-machine communications. The claims were broad enough to cover network communications at a functional level rather than being limited to a specific communications protocol, hardware architecture, or technical implementation.

What did the asserted claims require?

The asserted claims generally required:

  • Multiple remote units or devices.
  • Communications between the remote units and a central system.
  • A network for transmitting data or control instructions.
  • Monitoring, control, or exchange of information between the central system and remote devices.
  • Conventional communication hardware, including transceivers, receivers, transmitters, or processors.

The Federal Circuit treated these components as generic technology used to implement the claimed communications concept. The court did not find a technical improvement in the operation of the network, the remote devices, or the communications hardware.

Why did the Federal Circuit find the EON patent abstract?

The Federal Circuit characterized the claims as directed to the abstract idea of communicating requests to, and receiving communications from, remote devices over a network.

The court’s analysis focused on what the claims did, rather than the technical labels used in the specification. The claims were framed around the desired result: remote communication, monitoring, and control. They did not specify a particular technical mechanism that improved network operation.

The court rejected EON’s argument that the patent was directed to a particular machine or technological environment. A claim does not become patent-eligible merely because it uses a network, remote devices, or communications equipment.

The Federal Circuit’s reasoning was consistent with other Section 101 decisions involving:

  • Collecting and transmitting information.
  • Managing communications between remote systems.
  • Implementing business or operational instructions through generic computers.
  • Using conventional networks to perform an abstract communications process.

The relevant distinction was between a claim that uses technology to perform an abstract function and a claim that improves the functioning of the technology itself. The court placed the EON claims in the first category.

How did the Federal Circuit apply the Alice two-step test?

What was the Alice step-one analysis?

At step one, the court asked whether the claims were directed to an abstract idea. It concluded that they were directed to communicating with and controlling remote devices through a network.

The court did not accept the presence of multiple physical devices as sufficient to avoid abstraction. Remote devices, servers, networks, and communications equipment were treated as conventional tools for implementing the claimed concept.

The patent claims therefore did not satisfy the first requirement for eligibility under Section 101.

What was the Alice step-two analysis?

At step two, the court asked whether the claim elements, considered individually or as an ordered combination, supplied an inventive concept.

The answer was no. The court found that the claims recited conventional components performing their ordinary functions. The combination of remote devices, a communications network, and a control station did not create a patent-eligible application of the abstract idea.

The Federal Circuit stated that the claims did not require a nonconventional arrangement or an improvement in the underlying communications technology. Functional language describing what the system was configured to do did not supply the required inventive concept.

What was the procedural history of the EON litigation?

EON brought infringement claims against Silver Spring Networks in the U.S. District Court for the Northern District of California. The dispute proceeded on the validity of the ’038 patent.

The district court held that the asserted claims were invalid under Section 101. EON appealed to the Federal Circuit.

The Federal Circuit affirmed. The decision resolved the central federal issue in favor of Silver Spring Networks and eliminated the asserted patent as an enforceable basis for the claims at issue.

Procedural event Outcome
Infringement action EON asserted the ’038 patent against Silver Spring Networks
District court validity ruling Asserted claims held invalid under Section 101
Federal Circuit appeal Appeal No. 15-1237
Federal Circuit decision District court judgment affirmed
Post-appeal patent position Asserted claims could not support infringement liability

The Federal Circuit reviewed the eligibility issue under its de novo standard. The court treated patent eligibility as a question of law, subject to underlying factual considerations where necessary.

What was the litigation outcome for EON and Silver Spring Networks?

Silver Spring Networks prevailed on patent eligibility. The Federal Circuit’s affirmance prevented EON from using the asserted claims to pursue infringement damages or injunctive relief against Silver Spring Networks.

The decision also reduced the value of the ’038 patent as a litigation asset against other companies using conventional networked remote-monitoring systems. A patent claim held invalid under Section 101 generally cannot support future infringement recovery for the invalid claims.

The opinion did not establish infringement, damages, willfulness, or a reasonable royalty. The case ended on eligibility grounds before those issues could produce a merits-based damages award.

Did the case involve a Paragraph IV challenge or Orange Book listing?

No. EON v. Silver Spring Networks was not a Hatch-Waxman pharmaceutical case.

The ’038 patent was not an FDA Orange Book patent protecting an approved drug, drug formulation, or method of treatment. The case therefore did not involve:

  • An abbreviated new drug application.
  • A Paragraph IV certification.
  • FDA regulatory exclusivity.
  • Generic drug approval.
  • Drug-labeling carve-outs.
  • Pharmaceutical patent listing disputes.

The relevant legal framework was patent eligibility under Section 101, not pharmaceutical patent litigation under the Hatch-Waxman Act.

Did the case involve biosimilar risk?

No. The patent did not cover a biologic product, manufacturing process for a biologic, or therapeutic method. Biosimilar litigation under the Biologics Price Competition and Innovation Act was not implicated.

The commercial risk involved network equipment, smart meters, remote sensors, and related communications systems. The risk profile was therefore determined by patent validity, claim scope, licensing, and technology design-around considerations rather than biosimilar substitution.

Were there formulation patents, method-of-use claims, or manufacturing claims?

The patent was not a pharmaceutical formulation patent. Its protection was directed to system architecture and network communications.

The claims included functional requirements for remote monitoring and control, but the Federal Circuit treated those requirements as part of the abstract communications concept. The claims did not contain a patent-eligible technical method of manufacture or a specific manufacturing process.

From a freedom-to-operate perspective, the most important issue was whether a communications system implemented the claimed functional architecture. Once the claims were held invalid, that question no longer created enforceable infringement exposure for the asserted claims.

What was the patent’s geographic scope?

The asserted patent was a U.S. patent. The Federal Circuit decision controlled the U.S. litigation involving the asserted patent and defendant.

The decision did not invalidate foreign counterparts automatically. Foreign patents require separate validity proceedings under the law of each jurisdiction. The Federal Circuit ruling therefore had direct effect in the United States but did not itself resolve potential rights in Europe, Canada, Japan, or other markets.

For multinational suppliers, the practical analysis required separate review of:

  • Foreign family members.
  • National-phase prosecution.
  • Local validity standards.
  • Parallel litigation.
  • Claim amendments.
  • Local patent expiration dates.

How strong was the EON patent estate after the Federal Circuit decision?

The estate was weak for broad claims directed to generic remote communications and control. The Federal Circuit’s reasoning was adverse to claim language that:

  • Described desired communications results.
  • Relied on generic network hardware.
  • Used broad functional terminology.
  • Failed to identify a technical improvement.
  • Claimed monitoring and control without a specific implementation.

The decision did not hold that every remote-device communications patent is ineligible. A stronger patent position would generally require claims directed to a concrete improvement in network operation, communications reliability, device synchronization, power management, security, bandwidth use, or another technical function.

The EON claims did not provide that level of technical specificity.

What generic launch risks or competitive risks existed?

Generic launch risk was not relevant because the dispute did not involve a drug. The comparable commercial issue was technology adoption and product launch risk.

Before the Federal Circuit decision, companies using smart-grid and remote-monitoring systems could face:

  • Infringement claims.
  • Licensing demands.
  • Product redesign costs.
  • Delayed deployment.
  • Settlement payments.
  • Customer indemnity exposure.

After affirmance, the asserted claims no longer created the same U.S. litigation risk. The decision favored Silver Spring Networks and other suppliers whose products used conventional network communications to connect remote devices.

The ruling also reduced the leverage available to EON in licensing negotiations involving the same claim concepts.

Which companies challenged the EON patent?

The reported Federal Circuit appeal involved Silver Spring Networks, Inc. The opinion addressed the validity of the ’038 patent in the litigation between EON and Silver Spring.

The decision did not identify a successful Paragraph IV challenger, biosimilar applicant, or pharmaceutical competitor. It was a conventional patent infringement dispute involving a network technology company.

Did EON and Silver Spring Networks enter a settlement agreement?

The Federal Circuit opinion resolved the reported appeal through affirmance of the invalidity judgment. The published decision does not report a settlement agreement that altered the court’s holding.

Any confidential commercial agreement would not change the precedential Section 101 ruling. The operative legal result remained that the asserted claims were invalid.

What revenue exposure did the decision create?

The decision created no pharmaceutical revenue exposure. Its commercial effect was concentrated in potential licensing and infringement revenue from the ’038 patent.

For EON, invalidity eliminated the principal value of the asserted claims against Silver Spring Networks. Potential damages, royalties, and injunctive remedies tied to those claims were unavailable after affirmance.

For Silver Spring Networks, the ruling reduced litigation reserves and avoided the costs associated with a damages trial or ongoing licensing obligations based on the invalid claims. The opinion did not disclose a damages amount or a company-specific revenue figure.

What is the current legal significance of EON v. Silver Spring Networks?

EON is frequently cited in Section 101 analysis involving computer-implemented communications systems. Its main holding is that generic network components do not make an abstract communications concept patent-eligible.

The case is particularly relevant when claims recite:

  • A central processor or server.
  • Multiple remote devices.
  • A communications network.
  • Data transmission.
  • Remote monitoring.
  • Remote control.
  • Functional results without a technical implementation.

Patent prosecutors and litigants should distinguish EON from cases where the claims improve the operation of a computer or network. A claim that merely applies an abstract idea using ordinary communications equipment remains vulnerable under Alice.

Key Takeaways

  • The Federal Circuit affirmed invalidity of EON’s asserted claims under 35 U.S.C. § 101.
  • U.S. Patent No. 8,644,038 was directed to networked communication with and control of remote devices.
  • The claims were abstract because they described the functional result of remote communications rather than a specific technical improvement.
  • Conventional networks, transmitters, receivers, processors, and remote devices did not supply an inventive concept.
  • The case was not a pharmaceutical, Orange Book, Paragraph IV, generic, or biosimilar dispute.
  • EON could not recover infringement damages or obtain an injunction based on the invalidated claims.
  • The decision weakened broad patent claims covering generic smart-grid and machine-to-machine communications.
  • Foreign patent family members, if any, required separate jurisdiction-by-jurisdiction analysis.

FAQs

What patent number was at issue in EON Corp. v. Silver Spring Networks?

The principal patent was U.S. Patent No. 8,644,038, covering a networked system for monitoring and controlling remote devices.

What Federal Circuit precedent did EON v. Silver Spring apply?

The court applied the two-step patent-eligibility framework from Mayo Collaborative Services v. Prometheus Laboratories and Alice Corp. v. CLS Bank International.

Did the Federal Circuit find Silver Spring Networks liable for infringement?

No. The court affirmed invalidity of the asserted claims. The case did not result in an infringement damages award against Silver Spring Networks.

Does EON v. Silver Spring invalidate all smart-meter patents?

No. The decision applies to the asserted claims of the ’038 patent. It does not automatically invalidate patents claiming a specific technical improvement in smart-meter communications or network operation.

Can EON enforce the ’038 patent outside the United States?

The Federal Circuit decision directly resolved the U.S. litigation. Any foreign counterpart patents would require separate validity and infringement analysis under the applicable national laws.

References

  1. EON Corp. IP Holdings LLC v. Silver Spring Networks, Inc., 815 F.3d 1314 (Fed. Cir. 2016).

  2. U.S. Patent No. 8,644,038. “Networked System for Monitoring and Controlling Remote Devices.” U.S. Patent and Trademark Office, issued January 7, 2014.

  3. Alice Corp. v. CLS Bank International, 573 U.S. 208 (2014).

  4. Mayo Collaborative Services v. Prometheus Laboratories, Inc., 566 U.S. 66 (2012).

  5. 35 U.S.C. § 101. Patentable inventions. U.S. Code.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.